Skip to main content
Erschienen in: Breast Cancer Research 1/2000

01.03.2000 | Meeting abstract

Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer

verfasst von: O Stal, L Akerberg, B Nordenskjold, B Olsson, LE Rutqvist, L Skoog

Erschienen in: Breast Cancer Research | Sonderheft 1/2000

Einloggen, um Zugang zu erhalten

Excerpt

It has been suggested in several studies of breast cancer that overexpression of the growth factor receptor erbB2 is associated with less benefit from certain adjuvant treatments. The mechanisms are not fully understood. The erbB2 receptor activates several signal pathways including the phosphatidyl-inositol-3-kinase (PI3-K)/Akt (also known as PKB) pathway, which is implicated in cell survival. This pathway has shown to be a target of the tumor suppressor PTEN. …
Metadaten
Titel
Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer
verfasst von
O Stal
L Akerberg
B Nordenskjold
B Olsson
LE Rutqvist
L Skoog
Publikationsdatum
01.03.2000
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe Sonderheft 1/2000
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr106

Weitere Artikel der Sonderheft 1/2000

Breast Cancer Research 1/2000 Zur Ausgabe

Meeting abstract

REAL Real-Time!

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.